Fig. 7.
Tumour volume change for PSN-1 subcutaneous transplantation in female nude mice when treated with a DEBIRI (
3.3 mg; – 6.6 mg) B) DEBTOP (
0.2 mg; ···0.4 mg). The control (− −) in both cases were unloaded beads in alginate solution. Repeat injections were made for 3.3 mg DEBIRI (22 and 36 days); 6.6 mg DEBIRI (19 days); 0.4 mg DEBTOP (19 and 27 days) and 0.2 mg DEBTOP (19, 27 and 36 day). (n = 3, mean ± max/min)